SK Bioscience Extends Manufacturing Deal with CEPI
SEOUL, Oct. 6 (Korea Bizwire) — South Korean drugmaker SK Bioscience Co. said Wednesday it has signed an agreement with the Coalition for Epidemic Preparedness Innovations (CEPI) to extend capacity reservations for manufacturing COVID-19 vaccines by the end of 2022. The agreement was signed between SK Bioscience CEO Ahn Jae-yong and Richard Hatchett, CEO of [...]